References
- Rosenman S, Anderson P. Does prodromal diagnosis delay early intervention? Aust NZ J Psychiatry 2011; 45:509–514.
- McGorry PD. Pre-emptive intervention in psychosis: agnostic rather than diagnostic. Aust NZ J Psychiatry 2011; 45:515–519.
- Correll CU, Hauser M, Auther AM, Cornblatt BA. Research in people with psychosis risk syndrome: a review of the current evidence and future directions. J Child Psychol Psychiatry 2010; 51:390-431.
- Yung AR, Nelson B. Young people at ultra high risk for psychosis: a research update. Early Interv Psychiatry 2011; 5:S52–57.
- McGorry P, Killackey E, Lambert T . Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust NZ J Psychiatry 2005; 39:1–30.
- Woods SW, Walsh BC, Saksa JR, McGlashan TH. The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome. Schizophr Res 2010; 123:199–207.
- McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust NZ J Psychiatry 2006; 40:616–622.
- Frances A. Opening Pandora's box: the 19 worst suggestions for DSM5. Psychiatric Times 11 February 2010, www.psychiatrictimes.com/dsm/content/article/10168/1522341.
- Preti A, Cella M. Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness. Schizophr Res 2010; 123:30–36.
- Moncrieff J. Questioning the ‘neuroprotective’ hypothesis: does drug treatment prevent brain damage in early psychosis or schizophrenia? Br J Psychiatry 2011; 198:85–87.
- Amminger GP, Schafer MR, Papageorgiou K . Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 2010; 67:146–154.
- Rose G. Strategy of prevention: lessons from cardiovascular disease Br Med J (Clin Res Ed) 1981;282:1847–1851.
- Cantor-Graae E. The contribution of social factors to the development of schizophrenia: a review of recent findings. Can J Psychiatry 2007; 52:277–286.